PregLem: New spin in gynecology
PregLem S.A. is tackling the genitourinary and reproductive space with a mix of novel compounds and new formulations of existing products. For the former, the company thinks it should have safety and efficacy advantages. For its improved formulations, convenience is the selling proposition.
PregLem spun out of Ipsen Group in 2006 with the goal of in-licensing compounds in preclinical and clinical development and